Nicotinell Liquorice 2mg medicated chewing gum

Nicotinell is a global brand of smoking cessation products. Originally developed as part of a pharmaceutical initiative to provide nicotine replacement therapy, the brand has been a staple in the market for decades. The products, including these medicated gums, are designed to help individuals quit smoking by managing withdrawal symptoms through controlled nicotine delivery.

The global footprint of Nicotinell manufacturing spans several locations across Europe and North America to ensure supply for various regional markets. Ownership of the brand has transitioned within the pharmaceutical industry; it was long associated with Novartis before becoming part of the GSK (GlaxoSmithKline) consumer healthcare portfolio. Through a strategic demerger and subsequent spin-off, the brand is now under the umbrella of Haleon, a dedicated consumer health giant headquartered in the United Kingdom.